ConductScience.org, home

Paper36071908

Phenytoin as seizure prophylaxis in hematopoietic stem cell transplantation with busulfan conditioning.

Germeraad RS and 2 others. Front Neurol, 2022. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. Phenytoin as seizure prophylaxis in hematopoietic stem cell transplantation with busulfan conditioning. Papers, record 36071908. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36071908

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Phenytoin as seizure prophylaxis in hematopoietic stem cell transplantation with busulfan conditioning.
PubMed
Journal
Front Neurol
PubMed
Year
2022
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
3
iCite
Relative citation ratio, by iCite
0.44
iCite
Revised in PubMed
2022-09-10
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Germeraad RSR S
2Demandt AMPA M P
3Rouhl RPWR P W

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References15

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
11606341Generalized seizures secondary to high-dose busulfan therapy.Ann Pharmacother1992https://conductscience.org/library/papers/1606341PubMed
29489642Electroencephalogram abnormality and high-dose busulfan in conditioning regimens for stem cell transplantation.Bone Marrow Transplant1998https://conductscience.org/library/papers/9489642PubMed
330915718Comparison of valproate and levetiracetam for the prevention of busulfan-induced seizures in hematopoietic stem cell transplantation.Int J Hematol2019https://conductscience.org/library/papers/30915718PubMed
416174888Phenytoin poisoning.Neurocrit Care2005https://conductscience.org/library/papers/16174888PubMed
519025431Optimal prevention of seizures induced by high-dose busulfan.Pharmacotherapy2008https://conductscience.org/library/papers/19025431PubMed
62265459The effect of hepatic enzyme inducers on busulfan neurotoxicity and myelotoxicity.Cancer Chemother Pharmacol1990https://conductscience.org/library/papers/2265459PubMed
727746112Association of busulfan exposure with survival and toxicity after haemopoietic cell transplantation in children and young adults: a multicentre, retrospective cohort analysis.Lancet Haematol2016https://conductscience.org/library/papers/27746112PubMed
824768668Free phenytoin toxicity.Am J Emerg Med2014https://conductscience.org/library/papers/24768668PubMed
92753072Pharmacokinetic and metabolic studies of high-dose busulphan in adults.Eur J Clin Pharmacol1989https://conductscience.org/library/papers/2753072PubMed
1030871976Association of Antiepileptic Medications with Outcomes after Allogeneic Hematopoietic Cell Transplantation with Busulfan/Cyclophosphamide Conditioning.Biol Blood Marrow Transplant2019https://conductscience.org/library/papers/30871976PubMed
1127722893Minimal incidence of neurotoxicity without prophylaxis during busulfan-based conditioning regimen in patients undergoing stem cell transplantation.Int J Hematol2016https://conductscience.org/library/papers/27722893PubMed
1230083882Comparison of levetiracetam with phenytoin for the prevention of intravenous busulfan-induced seizures in hematopoietic cell transplantation recipients.Cancer Chemother Pharmacol2018https://conductscience.org/library/papers/30083882PubMed
134612168Marrow transplantation in the busulfan-treated rat: preclinical model of aplastic anemia.J Natl Cancer Inst1974https://conductscience.org/library/papers/4612168PubMed
1427208016Levetiracetam for the prevention of busulfan-induced seizures in pediatric hematopoietic cell transplantation recipients.J Oncol Pharm Pract2017https://conductscience.org/library/papers/27208016PubMed
1534335446Epileptic Seizures After Allogeneic Hematopoietic Stem Cell Transplantation.Front Neurol2021https://conductscience.org/library/papers/34335446PubMed

Download CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
41557115Association of busulfan area under the curve with the development of neurotoxicity in children and adolescents receiving busulfan-containing conditioning regimens for stem cell transplantation.Int J Hematol2026https://conductscience.org/library/papers/41557115PubMed
40514011Seizure Prophylaxis and its Impact on Busulfan Pharmacokinetics and Dosing in a Novel Timed Sequential Protocol: MD Anderson Experience.Transplant Cell Ther2025https://conductscience.org/library/papers/40514011PubMed
40319193Mechanisms underlying seizures and hypothermia during busulphan administration.Bone Marrow Transplant2025https://conductscience.org/library/papers/40319193PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36071908

GET https://conductscience.org/api/papers/v1/36071908/authors